ORALONE Drug Patent Profile
✉ Email this page to a colleague
When do Oralone patents expire, and what generic alternatives are available?
Oralone is a drug marketed by Taro and is included in one NDA.
The generic ingredient in ORALONE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oralone
A generic version of ORALONE was approved as triamcinolone acetonide by TARO on October 1st, 1986.
Summary for ORALONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Patent Applications: | 4,082 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ORALONE |
DailyMed Link: | ORALONE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ORALONE
US Patents and Regulatory Information for ORALONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | ORALONE | triamcinolone acetonide | PASTE;DENTAL | 071383-001 | Jul 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |